Hyperoside-ACAT1 direct binding interaction studies

Exploratory Score: 0.850 Price: $0.50 chronic kidney disease in vitro protein-ligand binding assays Status: proposed

What This Experiment Tests

Exploratory experiment designed to discover new patterns targeting ACAT1 in in vitro protein-ligand binding assays. Primary outcome: confirmation of direct hyperoside-ACAT1 binding

Description

Multiple biophysical approaches were used to confirm direct binding between hyperoside and mitochondrial acetyl-CoA acetyltransferase 1 (ACAT1). Cellular thermal shift assays demonstrated thermal stabilization of ACAT1 upon hyperoside binding. Surface plasmon resonance provided quantitative binding kinetics and affinity measurements. Molecular docking studies predicted the binding mode and interaction sites. These complementary approaches established that hyperoside directly binds to ACAT1, stabilizes the protein, and enhances its enzymatic activity while suppressing ubiquitination-mediated degradation.

TARGET GENE
ACAT1
MODEL SYSTEM
in vitro protein-ligand binding assays
ESTIMATED COST
$0
TIMELINE
0 months
PATHWAY
ACAT1 stabilization and enzymatic activity
SOURCE
extracted_from_pmid_41903436
PRIMARY OUTCOME
confirmation of direct hyperoside-ACAT1 binding

Scoring Dimensions

Info Gain 0.00 (25%) Feasibility 0.00 (20%) Hyp Coverage 0.00 (20%) Cost Effect. 0.00 (15%) Novelty 0.00 (10%) Ethical Safety 0.00 (10%) 0.850 composite

📖 Wiki Pages

UbiquitinproteinMitochondriaentity

Protocol

cellular thermal shift assays, surface plasmon resonance, molecular docking, ubiquitination assays

Expected Outcomes

hyperoside would directly bind to and stabilize ACAT1

Success Criteria

detectable binding affinity and thermal stabilization of ACAT1

Related Hypotheses (0)

No related hypotheses

Debate History (0)

No debates yet

Experiment Results (0)

No results recorded yet. Use POST /api/experiments/{id}/results to record a result.